Skip to main content

Table 5 NRT regimens prescribed during the second NRT episode, according to year of start of episode

From: General practitioner prescribing of single and combination nicotine replacement therapy in the UK: a retrospective database study

NRT products Total 2008 2009 2010 2011 2012
  N= 7,868 N= 413 N= 1,518 N= 2,046 N= 2,421 N= 1,470
  n % n % n % n % n % n %
Patch only 3,947 50.17 287 69.49 889 58.56 1,021 49.90 1,124 46.43 626 42.59
Patch and gum 293 3.72 14 3.39 61 4.02 97 4.74 81 3.35 40 2.72
Patch and tablet 57 0.72 4 0.97 12 0.79 19 0.93 15 0.62 7 0.48
Patch and inhalator 1,159 14.73 45 10.90 206 13.57 314 15.35 373 15.41 221 15.03
Patch and lozenge 293 3.72 9 2.18 30 1.98 77 3.76 113 4.67 64 4.35
Patch and oral spray 160 2.03 0 0.00 0 0.00 0 0.00 55 2.27 105 7.14
Patch and nasal spray 22 0.28 2 0.48 3 0.20 5 0.24 7 0.29 5 0.34
Other monotherapy* 1475 18.75 41 9.93 265 17.46 405 19.79 481 19.87 283 19.25
Other dual therapy* 165 2.10 5 1.21 19 1.25 40 1.96 61 2.52 40 2.72
≥ 3 types of NRT 297 3.77 6 1.45 33 2.17 68 3.32 111 4.58 79 5.37
  1. *Non-patch products including gum, tablet, inhalator, lozenge, oral spray or nasal spray on their own or in combination with one other non-patch product.